EndPoints News: MPM and Longwood-backed Werewolf Therapeutics grabs $56 million to take tumors by night

Backed with the team from his last company, one of the key developers behind Keytruda has a new warchest in the race to bring immunotherapy into the tumor micro-environment.

Read the full story

EndPoints News

By Jason Mast